BIOMAT Database Logo BIOMAT Database Logo

Expression of hepatocyte growth factor and c-met in ulcerative colitis. 2000

S Kitamura, and S Kondo, and Y Shinomura, and K Isozaki, and S Kanayama, and Y Higashimoto, and T Minami, and T Kiyohara, and Y Yasunaga, and H Ishikawa, and T Ohtani, and S Ishiguro, and Y Matsuzawa
Department of Internal Medicine and Molecular Science, Graduate School of Medicine, Osaka University, Suita, Japan.

OBJECTIVE This study was designed to determine if the hepatocyte growth factor (HGF)-Met system is involved in the repair process of inflamed mucosa of ulcerative colitis (UC) and in the development of UC-associated colorectal cancer. METHODS HGF and c-met gene expressions were quantified in colonic mucosal specimens from healthy control subjects, patients with UC and patients with UC-associated colorectal cancer, using the competitive reverse transcription-polymerase chain reaction. Expression of HGF protein was determined by immunoblot analysis. Expression of c-Met protein was analyzed immunohistochemically. RESULTS HGF and c-met gene expressions were increased in inflamed mucosa of UC, compared with control subjects. Gene expression of HGF was also increased in the surrounding inflamed mucosa of UC-associated cancers. In cases in which the HGF gene expression was increased, an apparent increase in protein levels of HGF in inflamed mucosa of UC were observed by immunoblot analysis. The c-met gene was overexpressed in UC-associated cancers and a high level of immunoreactivity of the c-Met protein was immunohistochemically detected within the cancer cells. CONCLUSIONS We showed that HGF and c-met expression is increased in the inflamed mucosa of UC and that c-met is overexpressed in UC-associated colorectal cancers. These observations suggest HGF-Met system is involved in the repair process of the inflamed mucosa of UC and provide further support for the view that the inappropriate expressions of both HGF and c-met genes predispose to the development of colorectal cancer in patients with UC.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D007413 Intestinal Mucosa Lining of the INTESTINES, consisting of an inner EPITHELIUM, a middle LAMINA PROPRIA, and an outer MUSCULARIS MUCOSAE. In the SMALL INTESTINE, the mucosa is characterized by a series of folds and abundance of absorptive cells (ENTEROCYTES) with MICROVILLI. Intestinal Epithelium,Intestinal Glands,Epithelium, Intestinal,Gland, Intestinal,Glands, Intestinal,Intestinal Gland,Mucosa, Intestinal
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012004 Rectal Neoplasms Tumors or cancer of the RECTUM. Cancer of Rectum,Rectal Cancer,Rectal Tumors,Cancer of the Rectum,Neoplasms, Rectal,Rectum Cancer,Rectum Neoplasms,Cancer, Rectal,Cancer, Rectum,Neoplasm, Rectal,Neoplasm, Rectum,Rectal Cancers,Rectal Neoplasm,Rectal Tumor,Rectum Cancers,Rectum Neoplasm,Tumor, Rectal
D003093 Colitis, Ulcerative Inflammation of the COLON that is predominantly confined to the MUCOSA. Its major symptoms include DIARRHEA, rectal BLEEDING, the passage of MUCUS, and ABDOMINAL PAIN. Colitis Gravis,Idiopathic Proctocolitis,Inflammatory Bowel Disease, Ulcerative Colitis Type,Ulcerative Colitis
D003106 Colon The segment of LARGE INTESTINE between the CECUM and the RECTUM. It includes the ASCENDING COLON; the TRANSVERSE COLON; the DESCENDING COLON; and the SIGMOID COLON. Appendix Epiploica,Taenia Coli,Omental Appendices,Omental Appendix,Appendices, Omental,Appendix, Omental
D003110 Colonic Neoplasms Tumors or cancer of the COLON. Cancer of Colon,Colon Adenocarcinoma,Colon Cancer,Cancer of the Colon,Colon Neoplasms,Colonic Cancer,Neoplasms, Colonic,Adenocarcinoma, Colon,Adenocarcinomas, Colon,Cancer, Colon,Cancer, Colonic,Cancers, Colon,Cancers, Colonic,Colon Adenocarcinomas,Colon Cancers,Colon Neoplasm,Colonic Cancers,Colonic Neoplasm,Neoplasm, Colon,Neoplasm, Colonic,Neoplasms, Colon
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

S Kitamura, and S Kondo, and Y Shinomura, and K Isozaki, and S Kanayama, and Y Higashimoto, and T Minami, and T Kiyohara, and Y Yasunaga, and H Ishikawa, and T Ohtani, and S Ishiguro, and Y Matsuzawa
Co-expression of hepatocyte growth factor and c-Met predicts peritoneal dissemination established by autocrine hepatocyte growth factor/c-Met signaling in gastric cancer.
June 2012, International journal of cancer,
S Kitamura, and S Kondo, and Y Shinomura, and K Isozaki, and S Kanayama, and Y Higashimoto, and T Minami, and T Kiyohara, and Y Yasunaga, and H Ishikawa, and T Ohtani, and S Ishiguro, and Y Matsuzawa
Expression of hepatocyte growth factor mRNA, and c-met mRNA (hepatocyte growth factor receptor) in human liver tumours.
August 1994, Journal of hepatology,
S Kitamura, and S Kondo, and Y Shinomura, and K Isozaki, and S Kanayama, and Y Higashimoto, and T Minami, and T Kiyohara, and Y Yasunaga, and H Ishikawa, and T Ohtani, and S Ishiguro, and Y Matsuzawa
Hepatocyte growth factor/scatter factor expression and c-met in primary breast cancer.
February 1996, Surgical oncology,
S Kitamura, and S Kondo, and Y Shinomura, and K Isozaki, and S Kanayama, and Y Higashimoto, and T Minami, and T Kiyohara, and Y Yasunaga, and H Ishikawa, and T Ohtani, and S Ishiguro, and Y Matsuzawa
Expression of hepatocyte growth factor and c-MET in skull base chordoma.
January 2008, Cancer,
S Kitamura, and S Kondo, and Y Shinomura, and K Isozaki, and S Kanayama, and Y Higashimoto, and T Minami, and T Kiyohara, and Y Yasunaga, and H Ishikawa, and T Ohtani, and S Ishiguro, and Y Matsuzawa
C-met and hepatocyte growth factor expression in combined hepatocellular and cholangiocarcinoma.
January 2002, Oncology reports,
S Kitamura, and S Kondo, and Y Shinomura, and K Isozaki, and S Kanayama, and Y Higashimoto, and T Minami, and T Kiyohara, and Y Yasunaga, and H Ishikawa, and T Ohtani, and S Ishiguro, and Y Matsuzawa
Tumor angiogenesis, hepatocyte growth factor, and c-Met expression in endometrial carcinoma.
February 1998, Cancer,
S Kitamura, and S Kondo, and Y Shinomura, and K Isozaki, and S Kanayama, and Y Higashimoto, and T Minami, and T Kiyohara, and Y Yasunaga, and H Ishikawa, and T Ohtani, and S Ishiguro, and Y Matsuzawa
Increased hepatocyte growth factor and c-Met receptor expression in nasopharyngeal carcinoma.
January 2014, International journal of clinical and experimental medicine,
S Kitamura, and S Kondo, and Y Shinomura, and K Isozaki, and S Kanayama, and Y Higashimoto, and T Minami, and T Kiyohara, and Y Yasunaga, and H Ishikawa, and T Ohtani, and S Ishiguro, and Y Matsuzawa
[Insulin-like growth factor receptor, hepatocyte-derived growth factor receptor and telomerase expression in ulcerative colitis].
September 2006, Orvosi hetilap,
S Kitamura, and S Kondo, and Y Shinomura, and K Isozaki, and S Kanayama, and Y Higashimoto, and T Minami, and T Kiyohara, and Y Yasunaga, and H Ishikawa, and T Ohtani, and S Ishiguro, and Y Matsuzawa
Co-expression of hepatocyte growth factor and c-met in epithelial odontogenic tumors.
July 2012, Acta histochemica,
S Kitamura, and S Kondo, and Y Shinomura, and K Isozaki, and S Kanayama, and Y Higashimoto, and T Minami, and T Kiyohara, and Y Yasunaga, and H Ishikawa, and T Ohtani, and S Ishiguro, and Y Matsuzawa
Expression of hepatocyte growth factor and c-Met in hypopharyngeal squamous cell carcinoma.
January 2006, Acta oto-laryngologica,
Copied contents to your clipboard!